These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibozil. Knoll RW; Ciafone R; Galen M Conn Med; 1993 Sep; 57(9):593-4. PubMed ID: 8252847 [No Abstract] [Full Text] [Related]
3. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Marais GE; Larson KK Ann Intern Med; 1990 Feb; 112(3):228-30. PubMed ID: 2297197 [No Abstract] [Full Text] [Related]
4. Rhabdomyolysis associated with simvastatin-gemfibrozil therapy. Tal A; Rajeshawari M; Isley W South Med J; 1997 May; 90(5):546-7. PubMed ID: 9160078 [TBL] [Abstract][Full Text] [Related]
6. Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil. van Puijenbroek EP; Du Buf-Vereijken PW; Spooren PF; van Doormaal JJ J Intern Med; 1996 Dec; 240(6):403-4. PubMed ID: 9010388 [TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy. Pogson GW; Kindred LH; Carper BG Am J Cardiol; 1999 Apr; 83(7):1146. PubMed ID: 10190540 [No Abstract] [Full Text] [Related]
8. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. Landesman KA; Stozek M; Freeman NJ Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341 [TBL] [Abstract][Full Text] [Related]
9. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil. Alexandridis G; Pappas GA; Elisaf MS Am J Med; 2000 Aug; 109(3):261-2. PubMed ID: 11023440 [No Abstract] [Full Text] [Related]
10. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia. Mastroianni CM; d'Ettorre G; Forcina G; Lichtner M; Corpolongo A; Coletta S; Vullo V AIDS; 2001 Apr; 15(6):820-1. PubMed ID: 11371708 [No Abstract] [Full Text] [Related]
15. Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case. Lau TK; Leachman DR; Lufschanowski R Tex Heart Inst J; 2001; 28(2):142-5. PubMed ID: 11453128 [TBL] [Abstract][Full Text] [Related]
16. Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals. Horn M Arch Dermatol; 1996 Oct; 132(10):1254. PubMed ID: 8859048 [No Abstract] [Full Text] [Related]
17. Cerivastatin and gemfibrozil-induced cardiac rhabdomyolysis. Su M; Hoffman RS; Flomenbaum M Am J Forensic Med Pathol; 2002 Sep; 23(3):305-6. PubMed ID: 12198364 [No Abstract] [Full Text] [Related]
18. The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. Goldman JA; Fishman AB; Lee JE; Johnson RJ Arthritis Rheum; 1989 Mar; 32(3):358-9. PubMed ID: 2930608 [No Abstract] [Full Text] [Related]
19. Rhabdomyolysis and acute renal failure in a heart transplant recipient treated with hypolipemiants. de Alava E; Sola JJ; Lozano MD; Pardo-Mindán FJ Nephron; 1994; 66(2):242-3. PubMed ID: 8139752 [No Abstract] [Full Text] [Related]
20. Risk of adverse events with fibrates. Alsheikh-Ali AA; Kuvin JT; Karas RH Am J Cardiol; 2004 Oct; 94(7):935-8. PubMed ID: 15464682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]